Tyra Biosciences
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -126 | -122 | ||
EBITDA | -29,600 | -28,477 | -23,406 | -22,200 |
EBIT | -29,744 | -28,604 | -23,532 | -22,322 |
Net Income | -25,571 | -24,016 | -18,702 | -18,192 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -19,596 | -17,950 | -10,728 | -22,164 |
Cash | 91,966 | 103,892 | 99,490 | 254,366 |
Basic Shares | 52,871 | 58,874 | 58,668 | 52,228 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -353 | -296 | -140 | |
EBITDA | -104,177 | -79,592 | -58,631 | -26,148 |
EBIT | -79,945 | -58,927 | -26,288 | |
Net Income | -86,481 | -69,134 | -51,723 | -26,141 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -50,212 | 286,958 | ||
Free Cash Flow | -70,438 | -50,909 | -50,844 | -24,406 |
Cash | 91,966 | 58,006 | 251,213 | 302,182 |
Basic Shares | 57,217 | 42,704 | 41,883 | 41,441 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.43 |
2024-09-30 | -$0.41 |
2024-06-30 | -$0.32 |
2024-03-31 | -$0.35 |
